Breaking News


Guidelines for the management of psoriasis and psoriatic arthritis: Focus on topical therapies


Recent guidelines on the use of topical therapies for psoriasis and psoriatic arthritis have been published. Levels of evidence were classified as good quality, patient-oriented (I), limited quality, patient-oriented (II) or "other" consensus guidelines, case studies (III). The strength of the clinical recommendations was graded as consistent, good quality (A), inconsistent, limited quality (B) or other (C). The following therapies were reviewed (the strength of recommendation and level of evidence are given in parentheses): class I corticosteroids (A1); class II corticosteroids (B11); class III-VI corticosteroids (A1); vitamin D analogues (A1); tazarotene (A1); tacrolimus and pimecrolimus (B11); anthralin (C111); coal tar (B11). Combination treatments reviewed included: corticosteroids/salicylic acid (B11); corticosteroids/vitamin D (A1); corticosteroids/tazarotene (A1); tacrolimus/salicylic ...

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here

return to breaking news list